Bret Walker

An appeals court has found US drug maker Cosette could not rely on sales performance figures to justify its termination of a $672 million merger agreement with Mayne Pharma Group. 

Insurer Nautilus has secured an extension to serve a writ on a slew of reinsurers as it awaits a High Court decision on whether to revive a class action against former NAB super fund trustee NULIS Nominees over $165 million in conflicted remuneration.

Mobile gaming company Playtika wants to stay the lead plaintiff’s claims in a novel class action alleging its online social casino games run afoul of interactive gambling laws, citing an arbitration clause in its terms and conditions. 

The Australian Centre for International Commercial Arbitration wants to make submissions in a High Court challenge to an arbitration ruling in a dispute with Esso over Bass Strait hydrocarbon royalties.

The applicant in a failed class action against former NAB super fund trustee NULIS Nominees over $165 million in conflicted remuneration has won High Court leave to challenge the dismissal of his case.

Former NAB super fund trustee NULIS Nominees has urged the High Court to reject a special leave application in a failed class action over $165 million in conflicted remuneration, saying the appeal is highly fact-specific and doesn't raise a matter of public importance.

A shareholder class action that succeeded in the Full Federal Court has argued that Worley's appeal to the High Court should be rejected, saying that its proof regarding market-based causation was “overwhelming”.

A class action against Allergan over recalled breast implants is trying again to strike out the US drug company’s defence that there was no known causal link between its implants and a type of cancer at the time of supply.

A class action against Allergan over recalled breast implants has lost its bid to strike out the US drug company’s defence that there was no known causal link between its implants and a certain form of cancer at the time of supply.

Inpex says damages against AkzoNobel could increase "very significantly" if the court adopts its position on a referee's report and it succeeds on liability in its suit over allegedly defective anti-corrosive coating used on the $45 billion Ichthys gas project.